Miyatake Shin-Ichi, Nonoguchi Noasuke, Furuse Motomasa, Yoritsune Erina, Miyata Tomo, Kawabata Shinji, Kuroiwa Toshihiko
Neurol Med Chir (Tokyo). 2015;55 Suppl 1:50-9.
New radiation modalities have made it possible to prolong the survival of individuals with malignant brain tumors, but symptomatic radiation necrosis becomes a serious problem that can negatively affect a patient’s quality of life through severe and lifelong effects. Here we review the relevant literature and introduce our original concept of the pathophysiology of brain radiation necrosis following the treatment of brain, head, and neck tumors. Regarding the pathophysiology of radiation necrosis, we introduce two major hypotheses: glial cell damage or vascular damage. For the differential diagnosis of radiation necrosis and tumor recurrence, we focus on the role of positron emission tomography. Finally, in accord with our hypothesis regarding the pathophysiology, we describe the promising effects of the anti-vascular endothelial growth factor antibody bevacizumab on symptomatic radiation necrosis in the brain.
新的放射治疗方式已使延长恶性脑肿瘤患者的生存期成为可能,但放射性坏死症状却成为一个严重问题,它可通过严重且长期的影响对患者生活质量产生负面影响。在此,我们回顾相关文献,并介绍我们关于脑、头颈部肿瘤治疗后脑放射性坏死病理生理学的原创概念。关于放射性坏死的病理生理学,我们介绍两个主要假说:胶质细胞损伤或血管损伤。对于放射性坏死与肿瘤复发的鉴别诊断,我们重点关注正电子发射断层扫描的作用。最后,根据我们关于病理生理学的假说,我们描述了抗血管内皮生长因子抗体贝伐单抗对脑放射性坏死症状的显著疗效。